Skip to main content
. Author manuscript; available in PMC: 2014 Feb 5.
Published in final edited form as: Virology. 2012 Dec 14;436(1):221–234. doi: 10.1016/j.virol.2012.11.014

Figure 4. Effect of JAK/STAT signaling inhibition on PDA cell susceptibility to VSV-ΔM51-GFP.

Figure 4

Cells were mock (DMSO) treated or treated with 0.5 or 2.5μM JAK Inh I for 48 h prior to infection with serial dilutions of VSV-ΔM51-GFP. At 17hpi, VSV-ΔM51-GFP fluorescent foci were counted to determine viral titers. Titers are expressed as a ratio to the mock treated titer, with the mock treated titer indicated. Titers were done in duplicate and data represent the mean ± standard error of mean. Treatments were compared using a 1-way ANOVA followed by the Bonferroni posttest for multiple comparisons. *=p<0.05; **=p<0.01